McDonald WI, Compston A.,
Edan
G., et al. Recommended diagnostic criteria
for multiple sclerosis: guidelines from the International Panel on the diagnosis of
multiple sclerosis. Ann Neurol2001;
50: 121-7.
2.
Tintore. M., Rovira A.,
Martinez
MJ, et al. Isolated demyelinating syndromes:
comparison of different MR imaging criteria to predict conversion to clinically definite
multiple sclerosis . Am J Neuroradiol2000;
21: 702-6.
3.
Barkhof F., Filippi M.,
Miller
DH, et al. Comparison of MRI criteria at
first presentation to predict conversion to clinically definite multiple
sclerosis. Brain1997;
120(Pt 11): 2059-69.
4.
Fazekas F., Offenbacher H.,
Fuchs
S., et al. Criteria for an increased
specificity of MRI interpretation in elderly subjects with suspected multiple
sclerosis. Neurology1988;
38: 1822-5.
5.
Paty DW, Oger JJ,
Kastrukoff
LF, et al. MRI in the diagnosis of MS: a
prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal
banding, and CT. Neurology1988;
38: 180-5.
6.
Fazekas F., Barkhof F.,
Filippi
M., et al. The contribution of magnetic
resonance imaging to the diagnosis of multiple sclerosis.
Neurology1999; 53:
448-56. Review.
7.
Comi G., Filippi M.,
Barkhof
F., et al. Effect of early interferon
treatment on conversion to definite multiple sclerosis: a randomised
study. Lancet2001; 357:
1576-82.
8.
Jacobs LD, Beck RW,
Simon
JH, et al. Intramuscular interferon beta-1a
therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study
Group. N Engl J Med2000;
343: 898-904.
